Filing Details

Accession Number:
0001214659-22-000701
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-14 12:02:48
Reporting Period:
2022-01-12
Accepted Time:
2022-01-14 12:02:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1737287 Allogene Therapeutics Inc. ALLO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296549 Arie Belldegrun 210 East Grand Avenue
South San Francisco CA 94080
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-12 155,039 $12.60 195,039 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 371,883 Direct
Common Stock 1,798,163 Indirect See footnote
Common Stock 4,710,148 Indirect See footnote
Footnotes
  1. The reported securities were purchased by Bellco Legacy LLC at an average price of $12.60 per unit, calculated from the price range of $12.35 to $13.00.
  2. The securities are held in the name of Bellco Legacy LLC. Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun.
  3. The securities are held by Vida Ventures LLC (Vida), of which VV Manager LLC is the manager. The reporting person is a Senior Managing Director of VV Manager LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
  4. The securities are held in the name of Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are the managers.